Neurophysiologic evidence for a central sensitization in patients with fibromyalgia

Arthritis and Rheumatism

Volumn 48, Issue 5, 2003, Pages 1420-1429

  Desmeules, J A ^a   Cedraschi, C ^a   Rapiti, E ^a   Baumgartner, E ^a   Finckh, A ^a   Cohen, P ^a   Dayer, P ^a   Vischer, T L ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT;

ADULT; ALLODYNIA; ARTICLE; CONTROLLED STUDY; ELECTROSTIMULATION; FEMALE; FIBROMYALGIA; FLEXOR REFLEX; HUMAN; MAJOR CLINICAL STUDY; MALE; MECHANICAL STIMULATION; NERVE EXCITABILITY; NEUROPHYSIOLOGY; NOCICEPTION; OUTPATIENT; PAIN ASSESSMENT; PAIN THRESHOLD; PRIORITY JOURNAL; QUALITY OF LIFE; SENSITIVITY AND SPECIFICITY; SENSITIZATION; THERMAL STIMULATION;

FEMALE; FIBROMYALGIA; HUMANS; HYPERALGESIA; MALE; MIDDLE AGED; NOCICEPTORS; OUTPATIENTS; PAIN; PAIN MEASUREMENT; PAIN THRESHOLD; QUALITY OF LIFE; QUESTIONNAIRES; REFLEX; SELF CARE; SICKNESS IMPACT PROFILE;

EID: 0037990104     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.10893     Document Type: Article

References (81)

1. Hawley DJ, Wolfe F, Cathey MA. Pain, functional disability, and psychological status: a 12-month study of severity in fibromyalgia. J Rheumatol 1988;15:1551-6.
2. Russell IJ. Neurochemical pathogenesis of fibromyalgia syndrome. J Musculoskel Pain 1996;4:61-92.
3. Yunus MB. Towards a model of pathophysiology of fibromyalgia: aberrant central pain mechanisms with peripheral modulation. J Rheumatol 1992;19:846-50.
4. Staud R, Vierck CJ, Cannon RL, Mauderli AP, Price DD. Abnormal sensitization and temporal summation of second pain (wind-up) in patients with fibromyalgia syndrome, Pain 2001;91: 165-75.
5. Kosek E, Ekholm J, Hansson P. Increased pressure pain sensibility in fibromyalgia patients is located deep to the skin but not restricted to muscle tissue. Pain 1995;63:335-9.
6. Kosek E, Ekholm J, Hansson P. Sensory dysfunction in fibromyalgia patients with implications for pathogenic mechanisms. Pain 1996;68:375-83.
7. Berglund B, Harju EL, Kosek E, Lindblom U. Quantitative and qualitative perceptual analysis of cold dysesthesia and hyperalgesia in fibromyalgia. Pain 2002;96:177-87.
8. Pillemer SR, Bradley LA, Crofford LJ, Moldofsky H, Chrousos GP. The neuroscience and endocrinology of fibromyalgia. Arthritis Rheum 1997;40:1928-39.
9. Kosek E, Hansson P. Modulatory influence on somatosensory perception from vibration and heterotopic noxious conditioning stimulation (HNCS) in fibromyalgia patients and healthy subjects. Pain 1997;70:41-51.
10. Jensen TS, Gottrup H, Kasch H, Nikolajsen L, Terkelsen AJ, Witting N. Has basic research contributed to chronic pain treatment? Acta Anaesthesiol Scand 2001;45:1128-35.
11. Woolf CJ, Salter MW. Neuronal plasticity: increasing the gain in pain. Science 2000;288:1765-9.
12. Kosek E, Ordeberg G. Lack of pressure pain modulation by heterotopic noxious conditioning stimulation in patients with painful osteoarthritis before, but not following, surgical pain relief. Pain 2000;88:69-77.
13. Mountz JM, Bradley LA, Modell JG, Alexander RW, Triana-Alexander M, Aaron LA, et al. Fibromyalgia in women: abnormalities of regional cerebral blood flow in the thalamus and the caudate nucleus are associated with low pain threshold levels. Arthritis Rheum 1995;38:926-38.
14. Kwiatek R, Barnden L, Tedman R, Jarrett R, Chew J, Rowe C, et al. Regional cerebral blood flow in fibromyalgia: single-photon-emission computed tomography evidence of reduction in the pontine tegmentum and thalami. Arthritis Rheum 2000;43: 2823-33.
15. Russell IJ, Orr MD, Littman B, Vipraio GA, Alboukrek D, Michalek JE, et al. Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum 1994;37:1593-601.
16. Sorensen J, Bengtsson A, Ahlner J, Henriksson KG, Ekselius L, Bengtsson M. Fibromyalgia: are there different mechanisms in the processing of pain? A double blind crossover comparison of analgesic drugs. J Rheumatol 1997;24:1615-21.
17. Russell IJ, Vaeroy H, Javors M, Nyberg F. Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis. Arthritis Rheum 1992;35:550-6.
18. Sorensen J, Graven-Nielsen T, Henriksson KG, Bengtsson M, Arendt-Nielsen L. Hyperexcitability in fibromyalgia, a low level of 5-HIAA in the cerebrospinal fluid of fibromyalgic patients. J Rheumatol 1998;25:152-5.
19. Graven-Nielsen T, Aspegren Kendall S, Henriksson KG, Bengtsson M, Sorensen J, Johnson A, et al. Ketamine reduces muscle pain, temporal summation, and referred pain in fibromyalgia patients. Pain 2000;85:483-91.
20. Granot M, Buskila D, Granovsky Y, Sprecher E, Neumann L, Yarnitsky D. Simultaneous recording of late and ultra-late pain evoked potentials in fibromyalgia. Clin Neurophysiol 2001;112: 1881-7.
21. Lorenz J, Grasedyck K, Bromm B. Middle and long latency somatosensory evoked potentials after painful laser stimulation in patients with fibromyalgia syndrome. Electroencephalogr Clin Neurophysiol 1996;100:165-8.
22. Lautenbacher S, Rollman GB. Possible deficiencies of pain modulation in fibromyalgia. Clin J Pain 1997;13:189-96.
23. Guieu R, Serratrice G, Pouget J. Counter irritation test in primary fibromyalgia. Clin Rheumatol 1994;13:605-10.
24. Granges G, Littlejohn G. Pressure pain threshold in pain-free subjects, in patients with chronic regional pain syndromes, and in patients with fibromyalgia syndrome. Arthritis Rheum 1993;36: 642-6.
25. Desmeules JA, Cedraschi C, Rapiti E, Baumgartner E, Finckh A, Cohen P, et al. Fibromyalgia: a randomised, controlled trial of a treatment programme based on self-management. Submitted for publication.
26. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the multicenter criteria committee. Arthritis Rheum 1990;33:160-72.
27. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 2001;357:1191-4.
28. Lautenschläger J, Seglias J, Brückle W, Muller W. Comparisons of spontaneous pain and tenderness in patients with primary fibromyalgia. Clin Rheumatol 1991;10:168-74.
29. Dupuy HJ. The Psychological General Well Being (PGWB) index. In: Wengger NK, Mattson ME, Furberg CD, Elison J, editors. Assessment of quality of life in clinical trials of cardiovascular therapies. Washington (DC): Le Jacq Publishing; 1984. p. 770-83.
30. Perneger TV, Leplège A, Etter JF, Rougemont A. Validation of a French-language version of the MOS 36-item short form health survey (SF-36) in young healthy adults. J Clin Epidemiol 1995;8: 1051-60.
31. Burckhardt CS, Clark SR, Bennett RM. The Fibromyalgia Impact Questionnaire: development and validation. J Rheumatol 1991;18: 728-33.
32. Deluze C, Bosia L, Zirbs A, Chantraine A, Vischer TL. Electroacupuncture in fibromyalgia: results of a controlled trial. BMJ 1992;305:1249-52.
33. Baumgartner E, Finckh A, Cedraschi C, Vischer TL. A 6 year prospective study of a cohort of fibromyalgia patients. Ann Rheum Dis 2002;61:644-5.
34. Finckh A, Morabia A, Deluze C, Vischer TL. Validation of questionnaire-based response criteria of treatment efficacy in the fibromyalgia syndrome. Arthritis Care Res 1998;11:116-23.
35. Fruhstorfer H, Linblom U, Schmid WG. Method for quantitative estimation of thermal thresholds in patients. J Neurol Neurosurg Psychiatry 1976;39:1071-5.
36. Jamal GA, Hansen S, Weir AI, Ballantyne JP. An improved automated method for the measurement of thermal thresholds. 1. Normal subjects. J Neurol Neurosurg Psychiatry 1986;48:354-60.
37. Yarnitsky D, Ochoa JL. Studies of heat pain sensation in man: perception thresholds, rate of stimulus rise and reaction time. Pain 1990;40:85-91.
38. Claus D, Hilz MJ, Hummer B. Methods of measurement of thermal thresholds. Acta Neurol Scand 1987;76:288-96.
39. Jones SF, McQuay HJ, Moore RA, Hand CW. Morphine and ibuprofen compared using the cold pressor test. Pain 1988;34: 117-22.
40. Harris G, Rollman G. The validity of experimental pain measures. Pain 1983;17:369-76.
41. Garcia de Jalon PD, Harrison FJJ, Johnson KI, Kozma C, Schnelle K. A modified cold stimulation technique for the evaluation of analgesic activity on human volunteers. Pain 1985;22:183-9.
42. Sherrington CS. Flexion-reflex of the limb, crossed extension-reflex, and reflex stepping and standing. J Physiol 1910;40:28-121.
43. Kugelberg K, Eklund K, Grimby L. An electromyographic study of the nociceptive reflexes of the lower limb: mechanism of the plantar responses. Brain 1960;83:394-410.
44. Bathien N. Réflexes spinaux chez l'homme et niveau d'attention. Electroencephalogr Clin Neurophysiol 1971;3O:32-7.
45. Willer JC, Bathien N. Pharmacological modulations of the nociceptive flexion reflex in man. Pain 1977;3: 111-9.
46. Willer JC. Comparative study of perceived pain and nociceptive flexion reflex in man. Pain 1977;3:69-80.
47. Willer JC, Le Bars D, De Broucker T. Diffuse noxious inhibitory controls in man: involvement of an opioidergic link. Eur J Pharmacol 1990;82:347-55.
48. Willer JC. Nociceptive flexion reflexes as a tool for pain research in man. In: Desmedt JE, editor. Advances in neurology: motor control mechanisms in health and disease. New York: Raven Press; 1983. p. 809-27.
49. Arendt-Nielsen L, Brennum J, Sindrup S, Bak P. Electrophysiological and psychophysical quantification of temporal summation in the human nociceptive system. Eur J Appl Physiol 1994;68: 266-73.
50. Skljarevski V, Ramadan NM. The nociceptive flexion reflex in humans: review article. Pain 2002;96:3-8.
51. Piletta P, Prochet HC, Dayer P. Distinct central nervous system involvement of paracetamol and salicylate. In: Dubner R, Gebhart GF, Bond MR, editors. Pain research and clinical management. New York: Elsevier Science; 1990. p. 181-4.
52. Porchet H, Piletta P, Dayer P. Objective assessment of clonidine analgesia in man and influence of naloxone. Life Sci 1990;46: 991-8.
53. Desmeules J, Piguet V, Collart L, Dayer P. Contribution of monoaminergic modulation in tramadol analgesic effect. Br J Clin Pharmacol 1996;41:7-12.
54. Willer JC, Le Bars D, Bouhassira D, Danziger N. Exploration clinique de la nociception par des techniques de réflexologie. In: Brasseur L, Chauvin M, Guilbaud G, editors. Douleurs, bases fondamentales, pharmacologie, douleurs aiguës, douleurs chroniques, thérapeutique. Paris: Maloine; 1997. p. 107-15.
55. Desmeules JA, Kondo-Oestreicher M, Piguet V, Dayer P. Contribution of cytochrome P4502D6 phenotype to the neuromodulatory effects of dextromethorphan. J Pharmacol Exp Ther 1999; 288:607-12.
56. Bossard AE, Guirimand F, Fletcher D, Gaude-Joindreau V, Chauvin M, Bouhassira D. Interaction of a combination of morphine and ketamine on the nociceptive flexion reflex in human volunteers. Pain 2002;98:47-57.
57. Guirimand F, Dupont X, Brasseur L, Chauvin M, Bouhassira D. The effects of ketamine on the temporal summation (wind-up) of the R(III) nociceptive reflex and pain in humans. Anesth Analg 2000;90:408-14.
58. Le Bars D, Dickenson AH, Bessen JM. Diffuse noxious inhibitory controls (DNIC): effects on dorsal horn convergent neurones in the rat. Pain 1979;6:283-304.
59. Le Bars D, Dickenson AH, Bessen JM. Diffuse noxious inhibitory controls (DNIC): lack of effect on nonconvergent neurones and supraspinal involvement and theoretical implications. Pain 1979; 6:305-27.
60. Bouhassira D, Le Bars D, Bolgert F, Laplane D, Willer JC. Diffuse noxious inhibitory controls in humans: a neurophysiological investigation of a patient with a form of Brown-Sequard syndrome. Ann Neurol 1993;34:536-43.
61. Le Bars D, Villanueva L, Chitour D. Les mécanismes physiologiques du contrôle de la douleur, In: Brasseur L, Chauvin M, Guilbaud G, editors. Douleurs, bases fondamentales, pharmacologie, douleurs aiguës, douleurs chroniques, thérapeutique. Paris: Maloine; 1997. p. 23-39.
62. Willer JC, Boureau F, Albe-Fessard D. Supraspinal influences on nociceptive flexion reflex and pain sensation in man. Brain Res 1979;179:61-8.
63. Sorensen J, Graven-Nielsen T, Henriksson KG, Bengtsson M, Arendt-Nielsen L. Hyperexcitability in fibromyalgia. J Rheumatol 1998;25:152-5.
64. Coderre TJ, Katz J, Vaccarino AL, Melzack R. Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain 1993;52:259-85.
65. Yeomans DC, Proudfit HK. Nociceptive responses to high and low rates of noxious cutaneous heating are mediated by different nociceptors in the rat: electrophysiological evidence. Pain 1996;68: 141-50.
66. Le Bars D, Gozariu M, Cadden S. Animal models of nociception. Pharmacol Rev 2001;53:597-652.
67. Sandrini G, Antonaci F, Lanfranchi S, Milanov I, Danilov A, Nappi G. Asymmetrical reduction of the nociceptive flexion reflex threshold in cluster headache. Cephalalgia 2000;20:647-52.
68. Brami A, Brussel B, Willer JC, Le Bars D. An electrophysiological investigation into the pain-relieving effects of heterotopic nociceptive stimuli: probable involvement of a supraspinal loop. Brain 1987;110:1497-508.
69. Willer JC, De Broucker T, Le Bars D. Encoding of nociceptive thermal stimuli by diffuse noxious inhibitory controls in humans. J Neurophysiol 1989;62:1028-38.
70. Terkelsen AJ, Andersen OK, Hansen PO, Jensen TS. Effects of heterotopic- and segmental counter-stimulation on the nociceptive withdrawal reflex in humans. Acta Physiol Scand 2001;172:211-7.
71. Danziger N, Gautron M, Le Bars D, Bouhassira D. Activation of diffuse noxious inhibitory controls (DNIC) in rats with an experimental peripheral mononeuropathy. Pain 2001;91:287-96.
72. Coquoz D, Porchet H, Dayer P. Central analgesic effects of desipramine, fluvoxamine, and moclobemide after single oral dosing: a study in healthy volunteers. Clin Pharmacol Ther 1993; 54:339-44.
73. Richard JL, Bouzourène K, Gallant S, Ricciardi P, Sudre P, Iten A, et al. Validation et normes du SF-36 dans la population du canton de Vaud. Lausanne: Institut universitaire de médecine sociale et préventive; 2000. p. 10-2.
74. Willer JC, Barranquero A, Kahn MF, Salliere D. Pain in sciatica depresses lower limb nociceptive reflexes to sural nerve stimulation. J Neurol Neurosurg Psychiatry 1987;50:J-5.
75. Bach FW, Jensen TS, Kastrup J, Stigsby B, Dejgard A. The effect of intravenous lidocaine on nociceptive processing in diabetic neuropathy. Pain 1990;40:29-34.
76. Guieu R, Roussel P, Sedan R, Peragut JC, Serratrice G. Nociceptive flexion reflex of the leg: use after surgical treatment of herniated disk. Presse Med 1993;22:205-6.
77. Sandrini G, Arrigo A, Bono G, Nappi G. The nociceptive flexion reflex as a tool for exploring pain control systems in headache and other pain syndromes. Cephalalgia 1993;13:21-7.
78. Boureau F, Luu M, Doubrere JF. Study of experimental pain measures and nociceptive reflex in chronic pain patients and normal subjects. Pain 1991;44:131-8.
79. Lorenz J. Hyperalgesia or hypervigilance? An evoked potential approach to the study of fibromyalgia syndrome. Z Rheumatol 1998;57 Suppl 2:19-22.
80. Peters ML, Vlaeyen JW, van-Drunen C. Do fibromyalgia patients display hypervigilance for innocuous somatosensory stimuli? Application of a body scanning reaction time paradigm. Pain 2000; 86:283-92.
81. Craig AD, Chen K, Bandy D, Reinman EM. Thermosensory activation of insular cortex. Nature Neuroscience 2000;3:184-90.